Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL467974 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL120683 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL20267799 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL238123 | 0.97 | — | — | |
| SCHEMBL95867 | 0.94 | — | — | |
| Water SCHEMBL29080231 | 0.90 | — | — | |
| SCHEMBL9193186 | 0.90 | SMN1; SMN2 (0.35) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Chloroform SCHEMBL10841676 | 0.88 | SMN1; SMN2 (0.30) | SMN1; SMN2 | |
| SCHEMBL30569675 | 0.83 | — | — | |
| SCHEMBL30899237 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5196094-A | Separation of 1,1,1-trichloroethane from the lower alcohols by extractive distillation | Berg, Lloyd (US) | 1993-03-23 | — | — | US | claimed |
| JP-51149221-A | — | — | None | — | — | JP | disclosed |
| CN-113189213-A | Method for measuring molecular weight and molecular weight distribution of polysaccharides in ginseng traditional Chinese medicine | 天津中医药大学 | 2021-07-30 | — | — | CN | disclosed |
| US-9096531-B2 | Fused imidazole derivative | TOA EIYO LTD. (JP) | 2015-08-04 | — | — | US | disclosed |
| EP-2287212-B1 | A catalyst component for ethylene polymerization, preparation thereof and a catalyst comprising the catalyst component | CHINA PETROLEUM & CHEMICAL (CN) | 2014-03-26 | — | — | EP | disclosed |
| EP-2578573-A1 | FUSED IMIDAZOLE DERIVATIVE | TOA Eiyo Ltd. (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-20130065896-A1 | FUSED IMIDAZOLE DERIVATIVE | TOA EIYO LTD. (JP) | 2013-03-14 | — | — | US | disclosed |
| US-8268945-B2 | Catalyst component for ethylene polymerization, preparation thereof, and a catalyst comprising the catalyst component | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2012-09-18 | — | — | US | disclosed |
| EP-2459569-A1 | INSECTICIDAL 4-AMINO-THIENO[2,3-D]-PYRIMIDINE COMPOUNDS AND METHODS OF THEIR USE | Merial Limited (US) | 2012-06-06 | — | — | EP | disclosed |
| EP-2427429-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS | Abbott GmbH & Co. KG (DE) | 2012-03-14 | — | — | EP | disclosed |
| WO-1997035845-A1 | SUBSTITUTED 1-METHYL-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-02 | — | — | WO | disclosed |
| WO-1997001543-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-16 | — | — | WO | disclosed |
| EP-0374771-B1 | Production method for PvuI restriction endonuclease | TOYO BOSEKI (JP) | 1994-04-13 | — | — | EP | disclosed |
| US-5196094-A | Separation of 1,1,1-trichloroethane from the lower alcohols by extractive distillation | Berg, Lloyd (US) | 1993-03-23 | — | — | US | disclosed |
| EP-0108422-A1 | Flux removal solvent blend | THE DOW CHEMICAL COMPANY (US) | 1984-05-16 | — | — | EP | disclosed |
| US-4330533-A | Novel polysaccharide and hypocholesterol composition containing the same | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1982-05-18 | — | — | US | disclosed |
| US-4230800-A | METHANOL AS CARBON SOURCE | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1980-10-28 | — | — | US | disclosed |
| US-4075339-A | BACTERICIDES, VIRICIDES, ANTIBIOTICS | UNIVERSITY OF ILLINOIS FOUNDATION (US) | 1978-02-21 | — | — | US | disclosed |
| JP-S51149221-A | PREPARATION OF 3,3-DIMETHYL-4,6,6- TRIHALO-4-HEXENOIC ESTERS | SUMITOMO CHEM CO LTD | 1976-12-22 | — | — | JP | disclosed |
| US-3987035-A | GELDANAMYCIN DERIVATIVES, BACTERICIDES, VIRICIDES | UNIVERSITY OF ILLINOIS FOUNDATION (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065896-A1 | FUSED IMIDAZOLE DERIVATIVE | CACNA1E, CACNA1G, CACNA1A | LMNA 4407/4885ALDH1A1 4252/4885HSD17B10 4346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.